2,976
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Network pharmacology-based analysis in determining the mechanisms of Huoxin pill in protecting against myocardial infarction

, , , , , , & show all
Pages 1189-1200 | Received 08 Jan 2021, Accepted 30 Jul 2021, Published online: 07 Sep 2021

References

  • Agundez JA, Gonzalez-Alvarez DL, Vega-Rodriguez MA, Botello E, Garcia-Martin E. 2014. Gene variants and haplotypes modifying transcription factor binding sites in the human cyclooxygenase 1 and 2 (PTGS1 and PTGS2) genes. Curr Drug Metab. 15(2):182–195.
  • Al-Numair KS, Veeramani C, Alsaif MA, Chandramohan G. 2015. Influence of kaempferol, a flavonoid compound, on membrane-bound ATPases in streptozotocin-induced diabetic rats. Pharm Biol. 53(9):1372–1378.
  • Baldwin AS. Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 14:649–683.
  • Bo-Wen W, Ce Z, Fen-Tang G, Yan-Ling L, Fu Z, Ping X. 2018. Randomized controlled clinical study on Yiqi Huoxin Pill in the treatment of chronic heart failure. China J Trad Chinese Med Pharm. 33:5721–5723.
  • Chen LF, Mu Y, Greene WC. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. Embo J. 21(23):6539–6548.
  • Colinge J, Rix U, Bennett KL, Superti-Furga G. 2012. Systems biology analysis of protein-drug interactions. Proteomics Clin Appl. 6(1-2):102–116.
  • Frangogiannis NG. 2008. The immune system and cardiac repair. Pharmacol Res. 58(2):88–111.
  • Frangogiannis NG. 2014. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 11(5):255–265.
  • Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V. 2014. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42(Web Server issue):W32–38.
  • Higuchi Y, Chan TO, Brown MA, Zhang J, DeGeorge BR, Jr., Funakoshi H, Gibson G, McTiernan CF, Kubota T, Jones WK, et al. 2006. Cardioprotection afforded by NF-kappaB ablation is associated with activation of Akt in mice overexpressing TNF-alpha. Am J Physiol Heart Circ Physiol. 290(2):H590–598.
  • Huang C, Zheng C, Li Y, Wang Y, Lu A, Yang L. 2014. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Brief Bioinform. 15(5):710–733.
  • Huo X, Juergens S, Zhang X, Rezaei D, Yu C, Strauch ED, Wang JY, Cheng E, Meyer F, Wang DH, et al. 2011. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett’s epithelial cells. Am J Physiol Gastrointest Liver Physiol. 301(2):G278–286.
  • Kain V, Prabhu SD, Halade GV. 2014. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol. 109(6):444.
  • Li B, Yang M, Liu JW, Yin GT. 2016. Protective mechanism of quercetin on acute myocardial infarction in rats. Genet Mol Res. 15:15017117.
  • Liang X, Guo C, Ma J, Lu P. 2018. Treatment of stable angina pectoris of coronary heart disease patients by Huoxin wan (concentracted pill): a multicenter, randomized, double-blinded, placebo-controlled clinical trial. Chinese J Integrative Med. 38:289–294.
  • Liao J, Hao C, Huang W, Shao X, Song Y, Liu L, Ai N, Fan X. 2018. Network pharmacology study reveals energy metabolism and apoptosis pathways-mediated cardioprotective effects of Shenqi Fuzheng. J Ethnopharmacol. 227:155–165.
  • Liu G, Wong L, Chua HN. 2009. Complex discovery from weighted PPI networks. Bioinformatics. 25(15):1891–1897.
  • McDermott EP, O'Neill LA. 2002. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1. J Biol Chem. 277(10):7808–7815.
  • Pinero J, Bravo A, Queralt-Rosinach N, Gutierrez-Sacristan A, Deu-Pons J, Centeno E, Garcia-Garcia J, Sanz F, Furlong LI. 2017. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45(D1):D833–D839.
  • Rotllan N, Wanschel AC, Fernandez-Hernando A, Salerno AG, Offermanns S, Sessa WC, Fernandez-Hernando C. 2015. Genetic evidence supports a major role for Akt1 in VSMCs during atherogenesis. Circ Res. 116(11):1744–1752.
  • Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al. 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 6:13.
  • Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, et al. 2010. GeneCards Version 3: the human gene integrator. Database. 2010:baq020.
  • Saparov A, Ogay V, Nurgozhin T, Chen WCW, Mansurov N, Issabekova A, Zhakupova J. 2017. Role of the immune system in cardiac tissue damage and repair following myocardial infarction. Inflamm Res. 66(9):739–751.
  • Sato R, Vohra S, Yamamoto S, Suzuki K, Pavel K, Shulga S, Blume Y, Kurita N. 2020. Specific interactions between tau protein and curcumin derivatives: molecular docking and ab initio molecular orbital simulations. J Mol Graph Model. 98:107611.
  • Seo HW, Hung TM, Na M, Jung HJ, Kim JC, Choi JS, Kim JH, Lee HK, Lee I, Bae K, et al. 2009. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity. Arch Pharm Res. 32(11):1573–1579.
  • Xu Y, Hu H, Li Y, Cen R, Yao C, Ma W, Huang M, Yin Y, Gao H, Liu Y, et al. 2019. Effects of huoxin formula on the arterial functions of patients with coronary heart disease. Pharm Biol. 57(1):13–20.
  • Xue R, Fang Z, Zhang M, Yi Z, Wen C, Shi T. 2013. TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res. 41(Database issue):D1089–1095.
  • Yoon HY, Lee EG, Lee H, Cho IJ, Choi YJ, Sung MS, Yoo HG, Yoo WH. 2013. Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs. Int J Mol Med. 32(4):971–977.
  • Zhao J, Lv C, Wu Q, Zeng H, Guo X, Yang J, Tian S, Zhang W. 2019. Computational systems pharmacology reveals an antiplatelet and neuroprotective mechanism of Deng-Zhan-Xi-Xin injection in the treatment of ischemic stroke. Pharmacol Res. 147:104365.